Treatment outcome of patients with liver-only metastases from breast cancer after mastectomy: A retrospective analysis

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 9, 2011, Pages 1363-1370

  Duan, Xiao Feng ^a   Dong, Na Na ^a   Zhang, Ti ^a   Li, Qiang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Chemotherapy; Liver neoplasm; Metastases; Transcatheter arterial chemoembolization

Indexed keywords

ANTHRACYCLINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLOXURIDINE; FLUOROURACIL; IODINATED POPPYSEED OIL; METHOTREXATE; TAXANE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG SAFETY; HUMAN; INTERMETHOD COMPARISON; IRON DEFICIENCY ANEMIA; KIDNEY FUNCTION; LEUKOPENIA; LIVER FUNCTION; LIVER METASTASIS; LIVER ONLY METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; ORGAN SPECIFICITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054735087     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1008-y     Document Type: Article

References (30)

1. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6):897-907; discussion 907-898. doi:10.1097/01. sla.0000246847.02058.1b (Pubitemid 44270929)
2. Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110(12):2640-2647. doi:10.1002/cncr.23088 (Pubitemid 350250332)
3. Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer 39(17):2439-2449 (Pubitemid 37340158)
4. Belda T, Montalva EM, Lopez-Andujar R, Rosell E, Moya A, Gomez I, Mir J (2010) [Role of resection surgery in breast cancer liver metastases. Experience over the last 10 years in a reference hospital]. Cir Esp 88(3):167-173. doi:10.1016/j.ciresp. 2010. 05.005
5. Camacho LH, Kurzrock R, Cheung A, Barber DF, Gupta S, Madoff DC, Wallace MJ, Kim EE, Curley SA, Hortobagyi GN, Mavligit G (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109(11):2190-2196. doi:10.1002/cncr.22672 (Pubitemid 46801547)
6. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492-2502. doi:10.1001/jama.295.21.2492 (Pubitemid 43854964)
7. Cheung KL, Graves CR, Robertson JF (2000) Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26(2):91-102. doi:10.1053/ctrv. 1999.0151 (Pubitemid 30182241)
8. Elias D, Lasser P, Spielmann M, May-Levin F, el Malt O, Thomas H, Mouriesse H (1991) Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet 172(6):461-464
9. Fujita S, Akasu T, Moriya Y (2000) Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 30(1):7-11
10. Gadaleta CD, Ranieri G (2010) Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Crit Rev Oncol Hematol. doi:10.1016/j.critrevonc.2010.10.005
11. Goldhirsch A, Gelber RD, Castiglione M (1988) Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses. J Clin Oncol 6(1):89-97 (Pubitemid 18039996)
12. Hao XS, Chen KS, Liu H (2002) Analysis of female breast cancer descriptive epidemiology in Tianjin, China. Asian Pac J Cancer Prev 3(2):143-148
13. Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106(7):1624-1633. doi:10.1002/cncr.21778
14. Jakobs TF, Hoffmann RT, Schrader A, Stemmler HJ, Trumm C, Lubienski A, Murthy R, Helmberger TK, Reiser MF (2009) CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol 32(1):38-46. doi:10.1007/s00270-008-9384-7
15. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300. doi:10.3322/caac.20073
16. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K (2010) Metastatic behavior of breast cancer subtypes. J Clin Oncol 28(20):3271-3277. doi:10.1200/JCO.2009.25.9820
17. Li XP, Meng ZQ, Guo WJ, Li J (2005) Treatment for liver metastases from breast cancer: results and prognostic factors. World J Gastroenterol 11(24):3782-3787 (Pubitemid 41158071)
18. Lubrano J, Roman H, Tarrab S, Resch B, Marpeau L, Scotte M (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38(4):293-299. doi:10.1007/s00595-007-3617-2 (Pubitemid 351661111)
19. Mack MG, Straub R, Eichler K, Sollner O, Lehnert T, Vogl TJ (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 233(2):400-409. doi:10.1148/radiol.2332030454 (Pubitemid 39423798)
20. Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr (2009) Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation-intermediate and long-term survival rates. Radiology 253(3):861-869. doi:10.1148/radiol.2533081968
21. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518-524. doi: 10.1038/nature03799 (Pubitemid 41112921)
22. O'Reilly SM, Richards MA, Rubens RD (1990) Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 26(5):574-577 (Pubitemid 20259332)
23. Pagani O, Senkus E, Wood W, Colleoni M, Cufer T, Kyriakides S, Costa A, Winer EP, Cardoso F (2010) International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst 102(7):456-463. doi: 10.1093/jnci/djq029
24. Pouillart P, Jouvet M, Palangie T, Garcia-Giralt E, Bretaudeau B, Dorval T, Asselain B (1985) Hepatic metastases of breast cancer. Analysis of the parameters which influence the response to chemotherapy. Ann Gastroenterol Hepatol (Paris) 21(2):87-90 (Pubitemid 15075412)
25. Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, Hortobagyi GN (1999) Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference. Cancer 85(1):104-111. doi:10.1002/(SICI) 1097-0142 (19990101) 85:1<104:AID-CNCR15>3.0. CO;2-R (Pubitemid 29031363)
26. Rodriguez-Pinilla SM, Sarrio D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J (2006) Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 12(5):1533-1539. doi: 10.1158/1078-0432. CCR-05-2281
27. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55(1):26-31; discussion 32
28. Svetlovska D, Mardiak J (2005) Treatment strategy of early-stage breast cancer. Bratisl Lek Listy 106(11):362-365
29. Vogl TJ, Naguib NN, Nour-Eldin NE, Eichler K, Zangos S, Gruber-Rouh T (2010) Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. Eur Radiol 20(1):173-180. doi:10.1007/s00330-009-1525-0
30. Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF, Evans AJ (2003) Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89(2):284-290. doi:10.1038/sj.bjc.6601038 (Pubitemid 36976317)